Skip to main content
TipRanks
Go Ultimate75% OFF
TenNor Therapeutics logo

TenNor Therapeutics: Valuation, Funding & Investors

Westfield, New Jersey, United Stateswww.tennorx.comTherapeutics

TenNor Therapeutics is a clinical-stage company focused on developing innovative therapies to address unmet needs in infectious diseases. The company is advancing rifasutenizol, a potential groundbreaking treatment for Helicobacter pylori infection, marking a significant development in this area after more than three decades.

Leadership & Board

Key Executives

CEO & Founder
Zhenkun Ma
VP Clinical Operations
Xiaomei Wang

Latest Estimated Valuation

Total Amount Raised
$300M
Total Funding Rounds
1
Latest Funding Amount
$300M
Latest Funding Round
Series E

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Aug 14, 2025Series E$300.00M―

Investors

Investor NameFunding Round
AMR Action FundSeries E
Zhongshan Venture CapitalSeries E

Similar Companies

A snapshot of private companies similar to TenNor Therapeutics, helping you discover and navigate related company profiles.

Related News and Analysis